How can we help?

Life sciences and health tech

Ireland is a world leader in life sciences innovation and manufacturing. Access deep research, specialist facilities and talent, plus practical support to validate your solution, build evidence, and forge global partnerships.

Deeptech sector image

Explore opportunities in life sciences and health

Discover the research expertise, facilities and specialist support available across key areas of life sciences and health tech in Ireland.

Medical devices

Ireland’s established medtech ecosystem gives founders access to specialist research, clinical and industry expertise. BioInnovate at University of Galway helps teams identify unmet clinical needs and develop commercially viable health technologies.

Digital health

Software, apps and connected health platforms may also fall within medical-device regulation depending on their intended purpose. Health Innovation Hub Ireland can help companies access healthcare professionals and clinical environments to develop and validate new products.

Health AI

AI is creating new opportunities across diagnostics, clinical decision-making and health data. Depending on its intended purpose, an AI-enabled product may be regulated as a medical device and may also fall within the EU AI Act. Health Innovation Hub Ireland Ireland can help innovators connect with the health system, while the HPRA Innovation Office can provide early regulatory guidance.

Biotech

Researchers and founders developing therapeutics, biologics, advanced therapies, microbiome technologies, synthetic biology and drug-discovery platforms can access specialist expertise through Ireland’s biopharma ecosystem.  The HPRA Innovation Office can also give guidance. 

Diagnostics and precision medicine

Diagnostics, biomarkers, genomics and companion diagnostics can follow specific regulatory and evidence requirements. The HPRA offers early meetings and guidance for developers of in vitro diagnostic devices and performance studies.

Biomanufacturing

Ireland’s biopharma base gives founders access to manufacturing expertise and facilities. NIBRT provides specialist bioprocessing research, training and industry collaboration from its Dublin facility.

Starting a business in life sciences

Life sciences products can often take longer to develop and bring to market, with regulatory, clinical and manufacturing decisions shaping the journey early. Understand the route your product needs to follow before committing heavily to development.

Why Ireland for life sciences?

Ireland combines a major medtech and biopharma base with access to experienced regulatory, quality and manufacturing talent.

Founders can also draw on specialist research facilities and expertise through organisations such as CÚRAM at University of Galway and NIBRT in Dublin, alongside established medtech clusters in Galway and Limerick and biopharma activity around Dublin and Cork.

As an English-speaking EU member, Ireland also offers access to the EU market and a practical base for companies with US ambitions. Founders may benefit from the 12.5% corporation tax rate, 35% R&D tax credit and the Knowledge Development Box. 

New Content Item (2)

Plan the regulatory route first

  • Understand the formal classification of whether your product is a medicine, medical device, in vitro diagnostic or wellness product, as each follows a different approval route.
  • For medical devices, your intended purpose and claims help determine the risk class. Most devices above Class I require notified body assessment.
  • Software can also qualify as a medical device if it diagnoses, monitors or guides treatment.
  • Devices follow the EU MDR, while diagnostics follow the EU IVDR. Regulatory pathways vary by global regions. 
  • Build your quality management system alongside the product while complying to regulatory guidance. 
  • Develop and de-risk the product. This is a continuous process driven by R&D, testing and validation by subject matter experts.

Build clinical evidence early

  • Plan evidence in stages, from bench and usability testing through to pilot or first-in-human studies and larger clinical studies where required.  

  • Agree clinical endpoints with clinicians early, and design studies so the same evidence can support regulatory approval, reimbursement and adoption. 

  • Health Innovation Hub Ireland can support pilot and clinical validation studies within the Irish health system, while Ireland’s clinical research facilities can help with study design and delivery. 

  • Regulators, hospitals and payers may also want ongoing clinical and health-economic evidence showing the outcomes improved or costs saved.

From idea to clinical and commercial evidence

Life sciences ventures rarely follow a straight line from prototype to launch. Product development, regulation, clinical evidence and commercial validation often need to progress together.

Validate the unmet need

Confirm the clinical or healthcare problem with patients, clinicians, buyers or other users. Understand how it is managed today and what would need to improve for someone to adopt a new solution. 

Define the regulatory route

Determine how your product is classified and which rules apply. Engage the HPRA Innovation Office early if you need help understanding the pathway.   

Develop and de-risk the product

This is a continuous process driven by R&D, testing and validation by subject matter experts. 

Build clinical evidence

Plan the studies needed to demonstrate safety, performance or clinical value. Depending on the study, you may need HPRA authorisation and ethics approval through the relevant National Research Ethics Committee.

Launch, learn and scale

Once in market, continue gathering evidence, monitoring performance and strengthening the commercial case. Use early clinical and customer experience to support wider adoption and international growth. 
 

Explore supports for your sector

Frequently asked questions

It depends on your stage. Researchers in higher education institutions can use the Enterprise Ireland Commercialisation Fund to move technology towards a spin-out. Aspiring medtech founders can apply for the funded, 10-month BioInnovate fellowship in Galway. Startups can seek Pre-Seed Start Fund and High Potential Start-Up investment. There are other supports available through European funding pathways such as the EIC Accelerator and Horizon Europe. 

Start with the product’s intended purpose, its principal mode of action and the claims you will make. A product that acts by pharmacological, immunological or metabolic means is generally a medicine. Most other products used for diagnosis, monitoring or treatment fall under the medical device or in vitro diagnostic regulations. If you are unsure, the HPRA Innovation Office answers queries free of charge and in confidence.

Yes. Software qualifies as a medical device when it is intended for a medical purpose, such as diagnosis, monitoring or informing treatment decisions. Under Rule 11 of the MDR, most such software is Class IIa or higher and needs notified body assessment. AI-enabled devices in that category also fall under the EU AI Act’s high-risk requirements, which apply to them from 2 August 2028.

Early, before the design is fixed. Evidence requirements shape cost, timelines and the regulatory route. Medical devices need a clinical evaluation under the MDR and diagnostics a performance evaluation under the IVDR, while buyers and payers often want additional evidence on cost and outcomes. Health Innovation Hub Ireland can help you access clinicians and healthcare sites. Regulatory pathways vary by global regions. 

Usually, and the type of study decides which committee. Regulated clinical trials of medicines, clinical investigations of medical devices and IVD performance studies need an opinion from a National Research Ethics Committee, as well as HPRA authorisation or notification. Other studies go to a hospital or institutional ethics committee. In Ireland, using participants’ personal data for health research also generally requires their explicit consent.

 

It depends on the product. Health Innovation Hub Ireland connects companies with hospitals and primary care sites for real-world testing. NIBRT, at UCD, offers bioprocessing research and training in a pilot plant that replicates industrial biomanufacturing. University clinical research facilities can run studies with patients, and research centres and hospitals provide further specialist expertise and equipment. Enterprise Ireland Innovation Vouchers can help you work with third-level partners to support you. 

As soon as a regulatory question could change a development decision. The Innovation Office aims to reply within 20 working days and can point you to formal scientific advice. For most medical devices, CE marking requires assessment by a notified body such as NSAI, not the HPRA. 

Approval is only one step to market. Before launch, you also need clear answers on:

  • Who uses the product and who approves the purchase
  • What clinical and economic evidence that buyer needs
  • How it fits clinical workflows and IT systems, and what training staff will need
  • The reimbursement or procurement route in each target market
  • Manufacturing, quality management and post-market surveillance obligations
  • How will you fund your research and product development

Speak to a Startup Ireland advisor

Whether you’re looking to validate your startup idea or getting set to grow internationally, talk to an advisor to understand the relevant supports available and to navigate the first steps to access them. 

Contact Startup Ireland:

Phone lines are open Monday to Friday, 9am–5pm (Irish Standard Time).

Speak to a Startup Ireland advisor Image